mazdutide vs semaglutide versus for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial Mazdutide Demonstrates Superior Glycemic Control

Who benefits most remains unclear: people with low baseline carnitine, certain gut microbiome profiles, or those with insulin resistance might be better candidates

The structural modifications incorporated into CJC-1295 include D-alanine at position 2 to enhance resistance to enzymatic degradation, glutamine at position 8 to reduce asparagine rearrangement and prevent amide hydrolysis to aspartic acid, alanine at position 15 to enhance bioactivity, and leucine at position 27 to prevent methionine oxidation

GHK-Cu binds to copper-dependent enzymes (including lysyl oxidase) that cross-link and stabilize new collagen

It also appears to modulate the gastrointestinal side effects of GLP-1 activation, which may explain why tirzepatide is better tolerated despite being more potent